- Home
- EVOK
EVOK
Evoke Pharma Inc.
as of 12-15-2025 10:30am EST
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
| Founded: | 2007 | Country: | United States |
| Employees: | N/A | City: | SOLANA BEACH |
| Market Cap: | 18.4M | IPO Year: | 2013 |
| Target Price: | N/A | AVG Volume (30 days): | 30.4K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.88 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.94 - $10.99 | Next Earning Date: | 11-13-2025 |
| Revenue: | $14,424,652 | Revenue Growth: | 67.40% |
| Revenue Growth (this year): | 58.96% | Revenue Growth (next year): | 57.99% |
AI-Powered EVOK Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Evoke Pharma Inc. (EVOK)
10% Owner
Avg Cost/Share
$10.65
Shares
9,000
Total Value
$95,885.00
Owned After
29,000
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Klein Roger M. | EVOK | 10% Owner | Nov 6, 2025 | Sell | $10.65 | 9,000 | $95,885.00 | 29,000 |
Compare EVOK vs Leading Stocks
See how EVOK stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "EVOK Evoke Pharma Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.